PART III*-PRACTICE OF PHARMACY
- Sec. 20-605. Practice of pharmacy without license or temporary permit prohibited
- Sec. 20-606. (Formerly Sec. 20-178). Use of the title “pharmacist”
- Sec. 20-607. (Formerly Sec. 20-173). Certificate of license, temporary permit or registration to be available for inspection
- Sec. 20-608. (Formerly Sec. 20-174). Use of certificate of license, temporary permit or display document by unlicensed person prohibited
- Sec. 20-609. (Formerly Sec. 20-184). Pharmacy license to be posted. Business which is not a pharmacy prohibited from using words, displays or symbols indicating it is a pharmacy; exemption
- Sec. 20-609a. Use of electronic technology or telepharmacy by hospital. Quality assurance evaluations
- Sec. 20-610. (Formerly Sec. 20-166). Dispensing or retail sale of legend drugs, legend devices and certain other drugs by other than pharmacies and hospitals, prohibited
- Sec. 20-611. (Formerly Sec. 20-175b). Advertising legend drug prices
- Sec. 20-612. Only pharmacy may accept prescription for dispensing
- Sec. 20-612a. Confirmation of identification prior to release of controlled substance. Exceptions
- Sec. 20-613. (Formerly Sec. 21a-308). Dispensing of drug or legend device pursuant to prescription only; exceptions. Emergency dispensing of drug or device in care-giving, correctional or juvenile training institutions; regulations. Pharmacy technicians. Prescribing practitioner authorized to dispense own prescription, when
- Sec. 20-613a. Requests for controlled substance issued on results of answers to electronic questionnaire. Regulations
- Sec. 20-614. (Formerly Sec. 20-184b). Prescriptions: Form and content. Electronic data intermediaries
- Sec. 20-615. (Formerly Sec. 20-184c). Prescriptions: Pharmacy to assign serial number and maintain records. Transfer of records to another pharmacy
- Sec. 20-616. (Formerly Sec. 20-184d). Prescriptions: Refills; transfers
- Sec. 20-616a. Prescription refills for quantity of drug greater than initial quantity prescribed. Conditions
- Sec. 20-617. (Formerly Sec. 20-184e). Prescriptions: Notation of drug quantity, expiration date, generic name and drug manufacturer and MedWatch program information. Label information for generic drug substitutions
- Sec. 20-617a. Flavoring agent added to prescription product
- Sec. 20-618. (Formerly Sec. 21a-107). Repackaged drugs not considered misbranded, when
- Sec. 20-619. (Formerly Sec. 20-185a). Substitution of generic drugs. Regulations
- Sec. 20-620. (Formerly Sec. 20-185g). Pharmacist's duties towards Medicaid recipients: To obtain, record and maintain pertinent patient information about the recipient; to undertake a review of the drugs previously dispensed to the recipient and to offer to discuss the drugs to be dispensed and to counsel the recipient on their correct usage. Exception
- Sec. 20-621. (Formerly Sec. 20-185h). Relabeling and dispensing of parenteral medication in hospital and nursing home pharmacies: When allowed
- Sec. 20-622. (Formerly Sec. 20-180a). Licensed practitioners may authorize medication to be dispensed from a hospital emergency room
- Sec. 20-623. Sale of nonlegend drugs. Labels, packaging and contents. Penalty
- Sec. 20-624. Permit to sell nonlegend drugs
- Sec. 20-625. Nonlegend veterinary drugs
- Sec. 20-626. Confidentiality of pharmacy records
- Sec. 20-627. Nonresident pharmacy. Definitions. Certificate of registration. Requirements
- Sec. 20-628. Shipping, mailing or delivering legend devices or drugs
- Sec. 20-629. Denial, revocation or suspension of nonresident pharmacy certificate of registration. Referral by commission
- Sec. 20-630. Advertising
- Sec. 20-631. Collaborative drug therapy management agreements between pharmacists and physicians. Scope. Pharmacist competency requirements. Regulations
- Sec. 20-631a. Collaborative drug management agreements between pharmacists employed by community pharmacies and one or more physicians. Pilot program
- Sec. 20-631b. Collaborative drug therapy management agreements entered into prior to October 1, 2010
- Sec. 20-632. Regulatory action report re disciplinary action against persons with controlled substance registrations and sanctions against pharmacists or pharmacies
- Sec. 20-633. Administration of vaccines by licensed pharmacists. Regulations
- Sec. 20-633a. Pharmacy rewards program. Plain language summary. Violation
- Sec. 20-633b. Sterile compounding pharmacies. Requirements. Regulations
- Sec. 20-633c. Prescribing of opioid antagonists by licensed pharmacists. Regulations
- Sec. 20-634